
EU Health Union ignoring cardiology
While the EU has already presented rules to establish a European Health Data Space (EHDS) and Europe’s Plan against Cancer within its Medicines...

BioNTech and Ryvu Therapeutics enter into global collaboration
BioNTech SE and Ryvu Therapeutics S.A. announced that the companies have entered into a multi-target research collaboration targeting immune...

Solar Food’s protein from carbon dioxide gets authorisation
The regulatory approval as a novel food, given by the Singapore Food Agency (SFA), allows for the sale of food products containing Solein in...

Step Pharma presents promising cancer treatment
Since September 2022, STP938, the cancer inhibitor developed by Step Pharma SAS, has been undergoing clinical trials for the treatment of T and B...

Amgen wins race of top `22 deals with $26bn for Horizon thx
Horizon confirmed Amgen's interest in a press release. The American group is to offer around $116.5 for each share. The offer price is about 20...

Enhanc3D Genomics raises £10m in Series A financing
Existing private investors and Bioqube Ventures participated in Enhanc3D Genomics’ Series A financing. The company said it will use the proceeds to...

ExeVir receives EIB risk finance for multiple COVID-19 nanobody
With the resurgence of COVID-19 in China, ExeVir BIO sees commercial potential in the future treatment of immunocompromised people, who make up 3%...